Management of hemangiomas by propranolol: Epidemiological, clinical and therapeutic aspects: Retrospective study about 15 cases
The objective of this study was to determine the epidemiological, clinical and therapeutic profile of cutaneous hemangioma at the Niamey National Hospital. This is a retrospective study carried out over a period of 2 years, in the Unity of Dermatology and Venerology. Out of a total of 1648 consultat...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Our Dermatology Online
2018-02-01
|
| Series: | Nasza Dermatologia Online |
| Subjects: | |
| Online Access: | http://www.odermatol.com/issue-in-html/2018-1-2-hemangiomas/ |
| _version_ | 1811217845459091456 |
|---|---|
| author | Moussa Doulla Harouna Bako Laouali Salissou Maimouna M Ouédraogo Ide Hassane Mariama Abdoulaye Hassan Moumouni |
| author_facet | Moussa Doulla Harouna Bako Laouali Salissou Maimouna M Ouédraogo Ide Hassane Mariama Abdoulaye Hassan Moumouni |
| author_sort | Moussa Doulla |
| collection | DOAJ |
| description | The objective of this study was to determine the epidemiological, clinical and therapeutic profile of cutaneous hemangioma at the Niamey National Hospital. This is a retrospective study carried out over a period of 2 years, in the Unity of Dermatology and Venerology. Out of a total of 1648 consultations in 2 years, 33 cases of cutaneous angioma were identified; which represented 2%. The prevalence was predominantly female (80%) and the sex ratio M/F was 0.25. The age group 0-5 months was more represented (66.7%) with ages ranging 2 days and 24 months. Of the 33 cases of angioma, 25 were hemangiomas and 8 were malformations without any cardiac anomalie. Patients retained for the study were those with hemangioma (25 cases with 76%) who received the Propranolol protocol used in the oral dosage of 1 mg/kg/day for 24 months. Only 15 patients recovered totally from hemangioma. Tolerance was good in 93.3%. Conclusion: Several therapies still show their limit. Due to the often serious side effects with corticosteroids, treatment based on betablockers can be a way of the future, given the satisfaction of results and the good tolerance to these molecules. |
| first_indexed | 2024-04-12T07:01:28Z |
| format | Article |
| id | doaj.art-eb8f6da2ff254c4eb9647ec3677895c0 |
| institution | Directory Open Access Journal |
| issn | 2081-9390 |
| language | English |
| last_indexed | 2024-04-12T07:01:28Z |
| publishDate | 2018-02-01 |
| publisher | Our Dermatology Online |
| record_format | Article |
| series | Nasza Dermatologia Online |
| spelling | doaj.art-eb8f6da2ff254c4eb9647ec3677895c02022-12-22T03:43:00ZengOur Dermatology OnlineNasza Dermatologia Online2081-93902018-02-019171010.7241/ourd.20181.2 Management of hemangiomas by propranolol: Epidemiological, clinical and therapeutic aspects: Retrospective study about 15 casesMoussa Doulla0Harouna Bako1Laouali Salissou2 Maimouna M Ouédraogo3Ide Hassane4Mariama Abdoulaye5Hassan Moumouni6Department of Dermatology Venerology, National Hospital of Niamey, NigerNational Center Dermato-Leprosy, Niamey, NigerDepartment of Dermatology Venerology, National Hospital of Niamey, NigerDepartment of Dermatology Venerology, National Hospital of Niamey, NigerCardiology Department, National Hospital of Niamey, NigerDepartment of Dermatology Venerology, National Hospital of Niamey, NigerLaboratory of Cytology and Genetics, Faculty of Health Sciences, Niamey, Niger The objective of this study was to determine the epidemiological, clinical and therapeutic profile of cutaneous hemangioma at the Niamey National Hospital. This is a retrospective study carried out over a period of 2 years, in the Unity of Dermatology and Venerology. Out of a total of 1648 consultations in 2 years, 33 cases of cutaneous angioma were identified; which represented 2%. The prevalence was predominantly female (80%) and the sex ratio M/F was 0.25. The age group 0-5 months was more represented (66.7%) with ages ranging 2 days and 24 months. Of the 33 cases of angioma, 25 were hemangiomas and 8 were malformations without any cardiac anomalie. Patients retained for the study were those with hemangioma (25 cases with 76%) who received the Propranolol protocol used in the oral dosage of 1 mg/kg/day for 24 months. Only 15 patients recovered totally from hemangioma. Tolerance was good in 93.3%. Conclusion: Several therapies still show their limit. Due to the often serious side effects with corticosteroids, treatment based on betablockers can be a way of the future, given the satisfaction of results and the good tolerance to these molecules.http://www.odermatol.com/issue-in-html/2018-1-2-hemangiomas/Angioma; Hemangioma; Propranolol |
| spellingShingle | Moussa Doulla Harouna Bako Laouali Salissou Maimouna M Ouédraogo Ide Hassane Mariama Abdoulaye Hassan Moumouni Management of hemangiomas by propranolol: Epidemiological, clinical and therapeutic aspects: Retrospective study about 15 cases Nasza Dermatologia Online Angioma; Hemangioma; Propranolol |
| title | Management of hemangiomas by propranolol: Epidemiological, clinical and therapeutic aspects: Retrospective study about 15 cases |
| title_full | Management of hemangiomas by propranolol: Epidemiological, clinical and therapeutic aspects: Retrospective study about 15 cases |
| title_fullStr | Management of hemangiomas by propranolol: Epidemiological, clinical and therapeutic aspects: Retrospective study about 15 cases |
| title_full_unstemmed | Management of hemangiomas by propranolol: Epidemiological, clinical and therapeutic aspects: Retrospective study about 15 cases |
| title_short | Management of hemangiomas by propranolol: Epidemiological, clinical and therapeutic aspects: Retrospective study about 15 cases |
| title_sort | management of hemangiomas by propranolol epidemiological clinical and therapeutic aspects retrospective study about 15 cases |
| topic | Angioma; Hemangioma; Propranolol |
| url | http://www.odermatol.com/issue-in-html/2018-1-2-hemangiomas/ |
| work_keys_str_mv | AT moussadoulla managementofhemangiomasbypropranololepidemiologicalclinicalandtherapeuticaspectsretrospectivestudyabout15cases AT harounabako managementofhemangiomasbypropranololepidemiologicalclinicalandtherapeuticaspectsretrospectivestudyabout15cases AT laoualisalissou managementofhemangiomasbypropranololepidemiologicalclinicalandtherapeuticaspectsretrospectivestudyabout15cases AT maimounamouedraogo managementofhemangiomasbypropranololepidemiologicalclinicalandtherapeuticaspectsretrospectivestudyabout15cases AT idehassane managementofhemangiomasbypropranololepidemiologicalclinicalandtherapeuticaspectsretrospectivestudyabout15cases AT mariamaabdoulaye managementofhemangiomasbypropranololepidemiologicalclinicalandtherapeuticaspectsretrospectivestudyabout15cases AT hassanmoumouni managementofhemangiomasbypropranololepidemiologicalclinicalandtherapeuticaspectsretrospectivestudyabout15cases |